Centre will push boundaries on eye research

22 January 2019
A pioneering new research centre which could offer hope for those with some of the most serious eye conditions will be officially launched by Cambridge University Hospitals NHS Foundation Trust tonight (Tuesday, 22 January).

The Cambridge Eye Research Centre, which is part the Department of Ophthalmology at Addenbrooke’s Hospital, will investigate new treatments, tests, and ways of caring for patients.Professor Rupert Bourne

Experts aim to preserve vision for those with vision-threatening conditions, improve quality of life for those with chronic eye diseases, and reduce the side effects of some medicines.

They also want to prevent eye disease, which means exploring new ways of detecting it, identifying new drugs, pioneering new ways of delivering existing treatments, and examining how genes affect eye disease.

The centre, which has close links with the University of Cambridge, Anglia Ruskin University and pharmaceutical companies, says trials will involve patients and healthy volunteers.

At the heart of the operation is a dozen-strong team specialising in everything from glaucoma to retina and ocular trauma, and with access to some of the latest equipment.

They are led by co-directors Professor Rupert Bourne and Professor Keith Martin. Prof Bourne co-manages the Glaucoma Service at CUH and is an honorary consultant ophthalmic surgeon to Addenbrooke’s.  He is also professor of ophthalmology at Anglia Ruskin University’s Vision and Eye Research Unit.

Professor Martin is a consultant ophthalmologist at CUH, the inaugural professor of ophthalmology at the University of Cambridge and a specialist in the treatment of glaucoma. 

Among those addressing the launch event will be patron of Cam Sight, Dame Mary Archer, and chief executive officer of Fight for Sight, Michele Acton.

Professor Bourne said: “As a Trust we are proud to have some of the world’s leading clinician-scientists with expertise in a variety of subspecialty areas of ophthalmology that includes glaucoma, corneal, retinal, neuro-ophthalmology, mitochondrial diseases, uveitis, ophthalmic epidemiology, and paediatric ophthalmology.

“The launch of the research centre is another exciting development and means we can further extend our cutting- edge work for the benefit of thousands of patients from this region and further afield.”

Anyone interested is taking part in clinical trials can find more information by following the link below.